Physician
Bristol Hospital Multi Specialty Group, INC
Bristol Hospital Multi Specialty Group, INC was paid $7.60M by Medicaid between Jan 2018 and Dec 2024, across 119 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoBRISTOL HOSPITAL MULTI SPECIALTY GROUP, INC
BRISTOL, CT 06010
BRISTOL, CT 06010
33aNPI1649265679assigned 09/15/2005
33bProvider typePediatrics Physician
28Total paid$7.60M
24GClaims287,102
24DCodes billed119
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Connecticut
Rank by total paid#9 of 162
Median peer was paid$313K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,649 | $709K | |
| 2019 | 33,121 | $880K | |
| 2020 | 35,473 | $1.11M | |
| 2021 | 44,938 | $1.25M | |
| 2022 | 48,866 | $1.30M | |
| 2023 | 51,611 | $1.32M | |
| 2024incomplete | 51,444 | $1.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 95,474 | 72,349 | $3.39M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 59,615 | 45,810 | $1.55M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.5% | 16,112 | 5,234 | $342K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.1% | 5,504 | 4,434 | $311K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.7% | 7,116 | 5,784 | $279K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.9% | 5,152 | 4,126 | $147K |
| 93000 | 1.8% | 21,860 | 16,752 | $140K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 4,000 | 3,201 | $122K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.6% | 1,633 | 1,368 | $121K |
| 99223 | Prolong inpt eval add15 m | 1.3% | 2,362 | 1,815 | $100K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 3,365 | 2,628 | $96K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.2% | 1,268 | 1,019 | $90K |
107 more codes
| 99239 | Hospital discharge day management, more than 30 minutes | 1.1% | 3,447 | $84K |
| 95886 | <1% | 1,558 | $68K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 625 | $65K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,089 | $56K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 737 | $52K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,036 | $45K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,454 | $42K |
| 88342 | <1% | 1,906 | $36K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 508 | $32K |
| 94004 | <1% | 4,430 | $28K | |
| 95800 | <1% | 340 | $27K | |
| 20610 | <1% | 1,260 | $24K | |
| 73630 | <1% | 2,001 | $24K | |
| 88307 | <1% | 560 | $22K | |
| 99245 | <1% | 142 | $20K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,982 | $17K |
| 99205 | Prolong outpt/office vis | <1% | 228 | $16K |
| 51798 | <1% | 3,279 | $15K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 6,195 | $15K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 290 | $13K |
| 73560 | <1% | 1,106 | $13K | |
| 88313 | <1% | 1,203 | $12K | |
| 99442 | <1% | 541 | $11K | |
| 64615 | <1% | 360 | $11K | |
| 73030 | <1% | 966 | $10K | |
| 11721 | <1% | 1,912 | $9K | |
| 90688 | <1% | 1,211 | $9K | |
| 99243 | <1% | 127 | $8K | |
| 97597 | <1% | 762 | $8K | |
| 72110 | <1% | 383 | $8K | |
| 72114 | <1% | 292 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 928 | $7K |
| 99443 | <1% | 168 | $7K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 64 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 968 | $6K |
| 73565 | <1% | 519 | $5K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 87 | $5K |
| 90686 | <1% | 433 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 488 | $4K |
| 20553 | <1% | 262 | $4K | |
| 99406 | <1% | 835 | $4K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 99 | $3K |
| 95012 | <1% | 388 | $3K | |
| 73110 | <1% | 194 | $3K | |
| 94618 | <1% | 387 | $2K | |
| 95251 | <1% | 226 | $2K | |
| 95819 | <1% | 102 | $2K | |
| 99483 | Prolong outpt/office vis | <1% | 70 | $2K |
| 82962 | <1% | 1,741 | $2K | |
| 99242 | <1% | 31 | $2K | |
| 73140 | <1% | 195 | $2K | |
| 62323 | <1% | 47 | $2K | |
| 81000 | <1% | 959 | $2K | |
| 95913 | <1% | 13 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 105 | $1K |
| 95910 | <1% | 17 | $1K | |
| 73610 | <1% | 114 | $1K | |
| 20550 | <1% | 79 | $1K | |
| 20611 | <1% | 48 | $1K | |
| 95908 | <1% | 34 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,357 | $1K |
| 94010 | <1% | 349 | $1K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 65 | $1K |
| 76942 | <1% | 32 | $1K | |
| 99304 | <1% | 70 | $1K | |
| 99385 | <1% | 13 | $900.25 | |
| 85060 | <1% | 99 | $868.38 | |
| 94060 | <1% | 172 | $847.26 | |
| 99221 | <1% | 35 | $802.05 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 219 | $763.94 |
| 88141 | <1% | 81 | $688.80 | |
| 73502 | <1% | 44 | $684.55 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 179 | $619.06 |
| 52000 | <1% | 21 | $594.58 | |
| 99464 | <1% | 14 | $576.60 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 180 | $533.08 |
| 73130 | <1% | 38 | $521.10 | |
| 82270 | <1% | 294 | $425.59 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 27 | $367.47 |
| 99441 | <1% | 234 | $351.78 | |
| 27096 | <1% | 14 | $346.24 | |
| 90662 | <1% | 58 | $311.54 | |
| 93018 | <1% | 61 | $299.84 | |
| 72050 | <1% | 13 | $298.98 | |
| 90656 | <1% | 30 | $290.55 | |
| 88312 | <1% | 19 | $269.28 | |
| 73562 | <1% | 15 | $232.98 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $221.39 |
| 77002 | <1% | 15 | $186.60 | |
| 81003 | <1% | 2,791 | $178.34 | |
| 96161 | <1% | 32 | $178.20 | |
| 88304 | <1% | 27 | $148.72 | |
| 72170 | <1% | 13 | $68.88 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,286 | $64.52 |
| 93793 | <1% | 54 | $48.64 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 168 | $43.81 |
| G0008 | Administration of influenza virus vaccine | <1% | 174 | $30.00 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 20 | $7.32 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 20 | $4.74 |
| 99024 | <1% | 436 | $0.05 | |
| 81002 | <1% | 109 | $0.01 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 17 | $0.00 |
| 99000 | 0% | 1,035 | $0.00 | |
| 90694 | 0% | 15 | $0.00 | |
| 99397 | 0% | 52 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 18 | $0.00 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 0% | 81 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEANEY, CHRIS (PRESIDENT)